Reports for NATCO PHARMA (CANADA) INC

Company Name

NATCO PHARMA (CANADA) INC

Totals

Shortage reports

18

Actual shortage: 9 (50%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 9 (50%)

Discontinuation Reports

0

To be discontinued: 0
Discontinued: 0
Reversed: 0

Late reports

1 (6%)

Overdue reports

3 (33%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
NAT-CITALOPRAM 10MG TABLET Resolved 2018-11-23 2019-02-04 67518
NAT-DONEPEZIL 5MG TABLET Resolved 2018-07-13 2020-10-26 55625
NAT-DONEPEZIL 10MG TABLET Resolved 2018-07-13 2020-10-26 55630
NAT-ERLOTINIB 25MG TABLET Actual shortage 2020-12-03 2020-12-03 129536
NAT-ERLOTINIB 100MG TABLET Actual shortage 2020-12-03 2020-12-03 129550
NAT-ERLOTINIB 150MG TABLET Actual shortage 2020-12-03 2021-10-14 129553
NAT-ESCITALOPRAM 10MG TABLET Resolved 2019-02-15 2020-10-26 75793
NAT-ESCITALOPRAM 20MG TABLET Resolved 2019-02-15 2020-10-26 75799
NAT-LEVETIRACETAM 250MG TABLET Actual shortage 2019-02-15 2021-10-14 75810
NAT-LEVETIRACETAM 500MG TABLET Resolved 2018-10-19 2020-10-26 64878
NAT-LEVETIRACETAM 750MG TABLET Resolved 2019-04-17 2021-10-15 81921
NAT-QUETIAPINE 25MG TABLET Actual shortage 2018-10-31 2021-10-14 65944
NAT-QUETIAPINE 100MG TABLET Actual shortage 2019-04-17 2021-10-14 81900
NAT-QUETIAPINE 150MG TABLET Actual shortage 2019-04-23 2021-10-14 82236
NAT-QUETIAPINE 200MG TABLET Actual shortage 2019-04-17 2021-10-14 81903
NAT-QUETIAPINE 300MG TABLET Actual shortage 2019-04-17 2021-10-14 81906
NAT-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-11-23 2019-02-07 67512
NAT-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-11-23 2019-02-07 67515
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports